PLK1
overexpression suppresses homologous recombination and confers cellular
sensitivity to PARP inhibition.
Sci Rep. 2024
Dec 28;14(1):31276. doi: 10.1038/s41598-024-82724-w.
· Quantitative
imaging of RAD51 expression as a marker of platinum resistance in ovarian
cancer. ·
EMBO
Mol Med. 2021 May 7;13(5):e13366. doi: 10.15252/emmm.202013366. · ·
A
new bioinformatics approach identifies overexpression of GRB2 as a poor
prognostic biomarker for prostate cancer
Sci
Rep. 2021 Mar 11;11(1):5696. doi: 10.1038/s41598-021-85086-9. ·
NF-kB signaling
in cardiomyocytes is inhibited by sevoflurane and promoted by propofol.
FEBS Open Bio.
2020 Feb;10(2):259-267. doi: 10.1002/2211-5463.12783.
· A bioinformatics-to-clinic sequential
approach to analysis of prostate cancer biomarkers using TCGA datasets and
clinical samples: a new method for precision oncology? ·
Oncotarget. 2017 Aug
24;8(59):99601-99611. doi: 10.18632/oncotarget.20448. ·
NF-κB signaling mediates acquired
resistance after PARP inhibition. ·
Oncotarget. 2015 Feb 28;6(6):3825-39.
doi: 10.18632/oncotarget.2868. ·
LSD1
overexpression is associated with poor prognosis in basal-like breast
cancer, and sensitivity to PARP inhibition.
PLoS One. 2015
Feb 13;10(2):e0118002. doi: 10.1371/journal.pone.0118002.
· A DNA-damage selective role for BRCA1
E3 ligase in claspin ubiquitylation, CHK1 activation, and DNA repair.·
Curr Biol. 2012 Sep 25;22(18):1659-66.
doi: 10.1016/j.cub.2012.07.034. Epub 2012